Think of it as a bridge between active weight loss and long-term maintenance, especially during the critical months right after stopping GLP-1 therapy
Novo Nordisk, for example, has committed to a $6 billion investment in Denmark and an additional $2.3 billion in France
Similarly, those with SSI had a mortality rate of 25% (5 out of 20 patients), which was not significant (AOR 6.36, CI: 0.79-52.9)
Stolbov K, Hahn A, Benes B, Andel M, Treslov L
Hundreds of studies have linked small changes in weight to big benefits: Lower blood pressure : Reducing BMI by just 2.27 pointse.g., going from a BMI of 26 to a BMI of 23.7, or losing about 20 poundscan lower systolic and diastolic blood pressure by 5.79 mmHg and 3.36 mmHg, respectively
( 8 ) Studies have shown that some patients taking tirzepatide achieved a weight loss of nearly 27% over an 84-week period